1. Home
  2. IMMP vs BETR Comparison

IMMP vs BETR Comparison

Compare IMMP & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • BETR
  • Stock Information
  • Founded
  • IMMP 1987
  • BETR 2014
  • Country
  • IMMP Australia
  • BETR United States
  • Employees
  • IMMP N/A
  • BETR N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • BETR Finance: Consumer Services
  • Sector
  • IMMP Health Care
  • BETR Finance
  • Exchange
  • IMMP Nasdaq
  • BETR Nasdaq
  • Market Cap
  • IMMP 264.7M
  • BETR 226.0M
  • IPO Year
  • IMMP N/A
  • BETR N/A
  • Fundamental
  • Price
  • IMMP $2.05
  • BETR $12.75
  • Analyst Decision
  • IMMP Buy
  • BETR
  • Analyst Count
  • IMMP 2
  • BETR 0
  • Target Price
  • IMMP $8.50
  • BETR N/A
  • AVG Volume (30 Days)
  • IMMP 106.2K
  • BETR 44.1K
  • Earning Date
  • IMMP 11-26-2024
  • BETR 11-13-2024
  • Dividend Yield
  • IMMP N/A
  • BETR N/A
  • EPS Growth
  • IMMP N/A
  • BETR N/A
  • EPS
  • IMMP N/A
  • BETR N/A
  • Revenue
  • IMMP $2,563,302.00
  • BETR $86,179,000.00
  • Revenue This Year
  • IMMP N/A
  • BETR N/A
  • Revenue Next Year
  • IMMP $10.84
  • BETR N/A
  • P/E Ratio
  • IMMP N/A
  • BETR N/A
  • Revenue Growth
  • IMMP 9.59
  • BETR N/A
  • 52 Week Low
  • IMMP $1.58
  • BETR $12.41
  • 52 Week High
  • IMMP $3.34
  • BETR $45.50
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 55.82
  • BETR 31.25
  • Support Level
  • IMMP $1.85
  • BETR $13.69
  • Resistance Level
  • IMMP $2.06
  • BETR $15.54
  • Average True Range (ATR)
  • IMMP 0.10
  • BETR 0.91
  • MACD
  • IMMP 0.03
  • BETR -0.13
  • Stochastic Oscillator
  • IMMP 70.89
  • BETR 8.90

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About BETR Better Home & Finance Holding Company

Better Home & Finance Holding Co is a digital-first homeownership company whose services include mortgage, real estate, title, and homeowners insurance. The company has combined technology innovation and fresh thinking with a deep customer focus with the goal of revolutionizing the homeownership industry.

Share on Social Networks: